Left Atrium Reservoir Function Modulation in Patients With Atrial Fibrillation: Digoxin Versus Beta Blocker

NCT05540600 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Atrial Fibrillation
Left Atrial Rhythm

Interventions

DRUG: Digoxin 0.25 mg
DRUG: Bisoprolol

Sponsor

University of Monastir